by Konstantinos Gousias, Clinical Professor, University of Nicosia Medical School.
Introduction by Demetrios Kanakis, Professor of Pathology, University of Nicosia Medical School.
Glioblastomas account for 51 % of all primary malignant central nervous system tumors Their established therapy consists of a gross total resection when safely feasible, followed by adjuvant radio-, chemo- or radiochemotherapy and application of tumor treating fields. However, the current therapeutic regimen seems rather ineffective, since the survival of patients suffering from glioblastoma averages less than two years.
This lecture will provide an overview on the current clinical management of glioblastomas, on the future therapeutic perspectives as well as on the scientific contribution of the presenter in this field.